Pre-specified secondary analysis of DECISION in heart failure: after blinded withdrawal in 587 patients, CV death or worsening HF rose to 42.8 vs 5.9 events/100 patient-years when digoxin vs placebo was stopped (14 vs 2 events; RR 7.37).
Secondary analysisn = 587
van der Meer et al. Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in heart failure: the DECISION trial